skip to main content
Show Results with:

Results 1 - 10 of 14  for Everything in this catalogue

results 1 2 next page
Refined by: author: Loskog, Angelica remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Material Type:
Article
Add to My workspace

Gemcitabine reduces MDSCs, tregs and TGFβ-1 while restoring the teff/treg ratio in patients with pancreatic cancer

Eriksson, Emma et al.

Journal of translational medicine. Volume 14:Issue 1 (2016); pp 1-12 -- BioMed Central

Online access

2
Material Type:
Article
Add to My workspace

662. An Oncolytic Adenovirus Gene Therapy Targeting Both Tumor Cell Survival and Desmoplasia in Pancreatic Cancer

Milenova, Ioanna et al.

Molecular therapy. Volume 24:Number S1 (2016, May); pp S262- -- Cell Press

Online access

3
Material Type:
Article
Add to My workspace

516. A Novel Oncolytic Adenovirus Expressing Tumor Microenvironment Stimulators to Evoke and Facilitate Anti-Tumor Immune Responses

Wenthe, Jessica et al.

Molecular therapy. Volume 24:Number S1 (2016, May); pp S206- -- Cell Press

Online access

4
Material Type:
Article
Add to My workspace

IL-6 Signaling Blockade during CD40-Mediated Immune Activation Favors Antitumor Factors by Reducing TGF-β, Collagen Type I, PD-L1/PD-1

Eriksson, Emma et al.

The journal of immunology: official journal of the American Association of Immunologists. Volume 202:Number 3 (2019, February 1st); pp 787-798 -- Williams & Wilkins

Check library holdings

5
Material Type:
Article
Add to My workspace

Preclinical Evaluation of AdVince, an Oncolytic Adenovirus Adapted for Treatment of Liver Metastases from Neuroendocrine Cancer

Yu, Di et al.

Neuroendocrinology. Volume 105:Issue 1 (2017, January); pp 54-66

Online access

6
Material Type:
Article
Add to My workspace

Plasma proteomics in CML patients before and after initiation of tyrosine kinase inhibitor therapy reveals induced Th1 immunity and loss of angiogenic stimuli

Söderlund, Stina et al.

Elsevier -- 2016

Online access

7
Material Type:
Article
Add to My workspace

Plasma proteomics in CML patients before and after initiation of tyrosine kinase inhibitor therapy reveals induced Th1 immunity and loss of angiogenic stimuli

Söderlund, Stina et al.

Leukemia research. Volume 50 (2016, November); pp 95-103 -- Elsevier

Online access

8
Material Type:
Article
Add to My workspace

An anergic immune signature in the tumor microenvironment of classical hodgkin lymphoma is associated with inferior outcome

Hollander, Peter et al.

European journal of haematology. VOL 100; NUMBER 1, ; 2018, 88-97 -- Wiley-Blackwell

Check library holdings

9
Material Type:
Article
Add to My workspace

An anergic immune signature in the tumor microenvironment of classical Hodgkin lymphoma is associated with inferior outcome

Hollander, Peter et al.

European journal of haematology. Volume 100:Number 1 (2018); pp 88-97 -- Wiley

Online access

10
Material Type:
Article
Add to My workspace

748. A Clinical Trial Using Third Generation CD19 Targeting CAR T Cells for Relapsed Lymphoma and Leukemia

Enblad, Gunilla et al.

Molecular therapy. Volume 24:Number S1 (2016, May); pp S295-S296 -- Cell Press

Online access

Results 1 - 10 of 14  for Everything in this catalogue

results 1 2 next page

Refine Search Results

Creation date 

From To

Additional Features 

  1. Abstract  (5)
  2. No Abstract  (9)
  3. Refine further open sub menu

Searching Remote Databases, Please Wait